Cargando…

Comparison of Survival Between Irreversible Electroporation Followed by Chemotherapy and Chemotherapy Alone for Locally Advanced Pancreatic Cancer

Locally advanced pancreatic cancer (LAPC) has a dismal prognosis even after standard chemotherapy, and local progression contributes to nearly one-third of the deaths of these patients. As a local destructive method, irreversible electroporation (IRE) can feasibly treat LAPC. The aim of this study w...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Chaobin, Huang, Xin, Zhang, Yu, Cai, Zhiyuan, Lin, Xiaojun, Li, Shengping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6987260/ https://www.ncbi.nlm.nih.gov/pubmed/32038984 http://dx.doi.org/10.3389/fonc.2020.00006

Ejemplares similares

Survival Comparison of Neoadjuvant Chemotherapy Followed by Irreversible Electroporation Versus Conversional Resection for Locally Advanced Pancreatic Cancer
por: He, Chaobin, et al.
Publicado: (2021)

Comparison of combination therapies in the management of locally advanced pancreatic cancer: Induction chemotherapy followed by irreversible electroporation vs radiofrequency ablation
por: He, Chaobin, et al.
Publicado: (2020)

Irreversible Electroporation Plus Anti-PD-1 Antibody versus Irreversible Electroporation Alone for Patients with Locally Advanced Pancreatic Cancer
por: He, Chaobin, et al.
Publicado: (2021)

The Synergistic Role of Irreversible Electroporation and Chemotherapy for Locally Advanced Pancreatic Cancer
por: Gyftopoulos, Argyrios, et al.
Publicado: (2022)

A Novel Prediction Tool Based on Large Cohorts to Determine the Cancer-Specific Survival Probability of Patients With Locally Advanced Pancreatic Cancer After Irreversible Electroporation Treatment
por: He, Chaobin, et al.
Publicado: (2020)

Irreversible electroporation versus radiotherapy after induction chemotherapy on survival in patients with locally advanced pancreatic cancer: a propensity score analysis
por: He, Chaobin, et al.
Publicado: (2019)

Commentary: The Synergistic Role of Irreversible Electroporation and Chemotherapy for Locally Advanced Pancreatic Cancer
por: Granata, Vincenza, et al.
Publicado: (2022)

Immunomodulatory Effect after Irreversible Electroporation in Patients with Locally Advanced Pancreatic Cancer
por: He, Chaobin, et al.
Publicado: (2019)

Identification of Circulating Biomarkers and Construction of a Prognostic Signature for Survival Prediction in Locally Advanced Pancreatic Cancer After Irreversible Electroporation
por: He, Chaobin, et al.
Publicado: (2021)

Optimizing Patient Selection for Irreversible Electroporation of Locally Advanced Pancreatic Cancer: Analyses of Survival
por: Woeste, Matthew R., et al.
Publicado: (2022)

T‐cell activation and immune memory enhancement induced by irreversible electroporation in pancreatic cancer
por: He, Chaobin, et al.
Publicado: (2020)

Immunomodulatory Effect of Irreversible Electroporation Alone and Its Cooperating With Immunotherapy in Pancreatic Cancer
por: Tian, Guo, et al.
Publicado: (2021)

Survival Comparisons of Hepatic Arterial Infusion Chemotherapy With mFOLFOX and Transarterial Chemoembolization in Patients With Unresectable Intrahepatic Cholangiocarcinoma
por: Cai, Zhiyuan, et al.
Publicado: (2021)

Gemcitabine plus concurrent irreversible electroporation vs gemcitabine alone for locally advanced pancreatic cancer
por: Ma, Yang-Yang, et al.
Publicado: (2020)

Sequential Irreversible Electroporation for Locally Advanced Pancreatic Cancer
por: Ong, Daniel Yuxuan, et al.
Publicado: (2023)

Treatment of unresectable locally advanced pancreatic cancer with percutaneous irreversible electroporation (IRE) following initial systemic chemotherapy (LAP-PIE) trial: study protocol for a feasibility randomised controlled trial
por: Rai, Zainab L, et al.
Publicado: (2022)

MR and CT imaging characteristics and ablation zone volumetry of locally advanced pancreatic cancer treated with irreversible electroporation
por: Vroomen, Laurien G. P. H., et al.
Publicado: (2016)

Case report: Irreversible electroporation for locally advanced pancreatic cancer
por: Orcutt, Sonia, et al.
Publicado: (2017)

A Quantitative Clinicopathological Signature for Predicting Recurrence Risk of Pancreatic Ductal Adenocarcinoma After Radical Resection
por: He, Chaobin, et al.
Publicado: (2019)

The role of irreversible electroporation in promoting M1 macrophage polarization via regulating the HMGB1-RAGE-MAPK axis in pancreatic cancer
por: He, Chaobin, et al.
Publicado: (2021)

Arterial complication of irreversible electroporation procedure for locally advanced pancreatic cancer
por: Ekici, Yahya, et al.
Publicado: (2016)

Irreversible electroporation combined with chemotherapy for unresectable pancreatic carcinoma: a prospective cohort study
por: Liu, Shupeng, et al.
Publicado: (2019)

Irreversible electroporation combined with chemotherapy and PD-1/PD-L1 blockade enhanced antitumor immunity for locally advanced pancreatic cancer
por: Ma, Yangyang, et al.
Publicado: (2023)

A Novel Nomogram to Predict Survival in Patients With Recurrence of Pancreatic Ductal Adenocarcinoma After Radical Resection
por: He, Chaobin, et al.
Publicado: (2020)

CT Findings of Patients Treated with Irreversible Electroporation for Locally Advanced Pancreatic Cancer
por: Akinwande, Olaguoke, et al.
Publicado: (2015)

Systematic Review of Irreversible Electroporation Role in Management of Locally Advanced Pancreatic Cancer
por: Lafranceschina, Stefano, et al.
Publicado: (2019)

Score for the Overall Survival Probability of Patients With Pancreatic Adenocarcinoma of the Body and Tail After Surgery: A Novel Nomogram-Based Risk Assessment
por: He, Chaobin, et al.
Publicado: (2020)

The Effects of Different Induction Chemotherapy Cycles and Adjuvant Chemotherapy on the Survival Outcomes of Patients With Locally Advanced Nasopharyngeal Carcinoma
por: Liao, Shu, et al.
Publicado: (2022)

Exploration of Novel Pathways Underlying Irreversible Electroporation Induced Anti-Tumor Immunity in Pancreatic Cancer
por: Imran, Khan Mohammad, et al.
Publicado: (2022)

A Single-institution Experience with Open Irreversible Electroporation for Locally Advanced Pancreatic Carcinoma
por: Yan, Li, et al.
Publicado: (2016)

Simultaneous Gemcitabine and Percutaneous CT-Guided Irreversible Electroporation for Locally Advanced Pancreatic Cancer
por: Ma, Yangyang, et al.
Publicado: (2022)

Overall survival and cancer-specific survival in patients with surgically resected pancreatic head adenocarcinoma: A competing risk nomogram analysis
por: He, Chaobin, et al.
Publicado: (2018)

High-frequency irreversible electroporation improves survival and immune cell infiltration in rodents with malignant gliomas
por: Campelo, Sabrina N., et al.
Publicado: (2023)

An overview of the irreversible electroporation for the treatment of liver metastases: When to use it
por: Belfiore, Maria Paola, et al.
Publicado: (2022)

Concurrent chemoradiotherapy followed by adjuvant chemotherapy versus concurrent chemoradiotherapy alone in locally advanced cervical cancer: A systematic review and meta-analysis
por: Liu, Haonan, et al.
Publicado: (2022)

Modeling Combined Chemotherapy and Particle Therapy for Locally Advanced Pancreatic Cancer
por: Durante, Marco, et al.
Publicado: (2015)

Irreversible electroporation for the treatment of pancreatic neuroendocrine tumors
por: Papamichail, Michail, et al.
Publicado: (2016)

Efficacy of irreversible electroporation in human pancreatic adenocarcinoma: advanced murine model
por: Philips, Prejesh, et al.
Publicado: (2015)

M1 macrophage predicted efficacy of neoadjuvant camrelizumab combined with chemotherapy vs chemotherapy alone for locally advanced ESCC: A pilot study
por: Wang, Shu, et al.
Publicado: (2023)

Prognostic Model to Predict Cancer-Specific Survival for Patients With Gallbladder Carcinoma After Surgery: A Population-Based Analysis
por: He, Chaobin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9hf03o552952imfga7pfrchsot